產(chǎn)品詳情
簡單介紹：
Anti-phospho-c-Abl(Tyr272)抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-phospho-c-Abl(Tyr272)抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-phospho-c-Abl(Tyr272)
Cat. Number:
Anti-phospho-c-Abl(Tyr272)抗體KL-4085R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The c Abl proto oncogene encodes a protein tyrosine kinase that is located in the cytoplasm and nucleus. In chronic myelogenous leukemia and in a subset of acute lymphoblastic leukemias, the c Abl proto oncogene undergoes Anti-phospho-c-Abl(Tyr272)抗體a (9;22) chromosomal translocation producing a novel rearranged chromosome (the Philadelphia chromosome) As the result of the fusion of c Abl sequences from chromosome 9 to the Bcr gene on chromosome 22. The molecular consequence of this translocation is the generation of a chimeric Bcr/Abl mRNA encoding activated Abl protein tyrosine kinase.
Also known as:
c Abl (phospho Y272); p-c AblAnti-phospho-c-Abl(Tyr272)抗體 (phospho Y272); Abelson Murine Leukemia Viral Oncogene Homolog 1; Abelson murine leukemia viral v abl oncogene homolog 1; Abl 1; ABL; Abl protein; Abl1; Bcr/c abl oncogene protein; JTK 7; JTK7; p150 ; Proto oncogene tyrosine protein kinase ABL1; Transformation gene oncogene ABL; v abl Abelson murine leukemia viral oncogene homolog 1; v abl.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human c-Abl isoform b around the phosphorylation site of Tyr272.
●
Predicted Molecular Weight: Anti-phospho-c-Abl(Tyr272)抗體126kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-phospho-c-Abl(Tyr272)抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-phospho-c-Abl(Tyr272)抗體must be determined by the end user.
kl562Hu01 殺傷細(xì)胞**球蛋白樣受體3DL1(KIR3DL1)多克隆抗體 Polyclonal Antibody to Killer Cell Immunoglobulin Like Receptor 3DL1 (KIR3DL1)
kl564Hu01 干擾素調(diào)節(jié)因子1(IRF1)多克隆抗體 Polyclonal Antibody to Interferon Regulatory Factor 1 (IRF1)
kl564Mu01 干擾素調(diào)節(jié)因子1(IRF1)多克隆抗體 Polyclonal Antibody to Interferon Regulatory Factor 1 (IRF1)
kl566Hu01 肝型脂肪酸結(jié)合蛋白(FABP1)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 1, Liver (FABP1)
kl566Po01 肝型脂肪酸結(jié)合蛋白(FABP1)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 1, Liver (FABP1)
kl567Hu01 細(xì)胞間粘附分子4(ICAM4)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 4 (ICAM4)
kl568Hu01 血小板因子4V1(PF4V1)多克隆抗體 Polyclonal Antibody to Platelet Factor 4 Variant 1 (PF4V1)
kl570Hu01 粒細(xì)胞趨化蛋白2(GCP2)多克隆抗體 Polyclonal Antibody to Granulocyte Chemotactic Protein 2 (GCP2)
kl570Ra01 粒細(xì)胞趨化蛋白2(GCP2)多克隆抗體 Polyclonal Antibody to Granulocyte Chemotactic Protein 2 (GCP2)
kl571Mu01 胸腺激活調(diào)節(jié)趨化因子(TARC)多克隆抗體 Polyclonal Antibody to Thymus Activation Regulated Chemokine (TARC)
kl571Ra01 胸腺激活調(diào)節(jié)趨化因子(TARC)多克隆抗體 Polyclonal Antibody to Thymus Activation Regulated Chemokine (TARC)
kl572Hu01 **細(xì)胞功能關(guān)聯(lián)抗原1α(LFA1α)多克隆抗體 Polyclonal Antibody to Lymphocyte Function Associated Antigen 1 Alpha (LFA1a)
kl574Hu01 髓樣前體細(xì)胞抑制因子1(MPIF1)多克隆抗體 Polyclonal Antibody to Myeloid Progenitor Inhibitory Factor 1 (MPIF1)
kl575Hu01 二級**組織趨化因子(SLC)多克隆抗體 Polyclonal Antibody to Secondary Lymphoid Tissue Chemokine (SLC)
kl576Ra01 **細(xì)胞功能關(guān)聯(lián)抗原2(LFA2)多克隆抗體 Polyclonal Antibody to Lymphocyte Function Associated Antigen 2 (LFA2)
kl578Hu01 IgG-Fc片段受體Ⅰ(FcγRⅠ)多克隆抗體 Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin G (FcgRI)
kl579Hu01 IgG-Fc片段受體Ⅱ(FcγRⅡ)多克隆抗體 Polyclonal Antibody to Receptor II For The Fc Region Of Immunoglobulin G (FcgRII)
